General Information of the Protein
Protein ID
PT01566
Protein Name
Histone-lysine N-methyltransferase EHMT2
Secondarily
Protein Name
Euchromatic histone-lysine N-methyltransferase 2
HLA-B-associated transcript 8
Histone H3-K9 methyltransferase 3
Lysine N-methyltransferase 1C
Protein G9a
Gene Name
EHMT2
Secondarily
Gene Name
BAT8
C6orf30
G9A
KMT1C
NG36
Sequence
MAAAAGAAAAAAAEGEAPAEMGALLLEKETRGATERVHGSLGDTPRSEETLPKATPDSLEPAGPSSPASVTVTVGDEGADTPVGATPLIGDESENLEGDGDLRGGRILLGHATKSFPSSPSKGGSCPSRAKMSMTGAGKSPPSVQSLAMRLLSMPGAQGAAAAGSEPPPATTSPEGQPKVHRARKTMSKPGNGQPPVPEKRPPEIQHFRMSDDVHSLGKVTSDLAKRRKLNSGGGLSEELGSARRSGEVTLTKGDPGSLEEWETVVGDDFSLYYDSYSVDERVDSDSKSEVEALTEQLSEEEEEEEEEEEEEEEEEEEEEEEEDEESGNQSDRSGSSGRRKAKKKWRKDSPWVKPSRKRRKREPPRAKEPRGVNGVGSSGPSEYMEVPLGSLELPSEGTLSPNHAGVSNDTSSLETERGFEELPLCSCRMEAPKIDRISERAGHKCMATESVDGELSGCNAAILKRETMRPSSRVALMVLCETHRARMVKHHCCPGCGYFCTAGTFLECHPDFRVAHRFHKACVSQLNGMVFCPHCGEDASEAQEVTIPRGDGVTPPAGTAAPAPPPLSQDVPGRADTSQPSARMRGHGEPRRPPCDPLADTIDSSGPSLTLPNGGCLSAVGLPLGPGREALEKALVIQESERRKKLRFHPRQLYLSVKQGELQKVILMLLDNLDPNFQSDQQSKRTPLHAAAQKGSVEICHVLLQAGANINAVDKQQRTPLMEAVVNNHLEVARYMVQRGGCVYSKEEDGSTCLHHAAKIGNLEMVSLLLSTGQVDVNAQDSGGWTPIIWAAEHKHIEVIRMLLTRGADVTLTDNEENICLHWASFTGSAAIAEVLLNARCDLHAVNYHGDTPLHIAARESYHDCVLLFLSRGANPELRNKEGDTAWDLTPERSDVWFALQLNRKLRLGVGNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLDPHPELLPELGSLPPVNT
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Epigenetic regulator
>
Writer
>
Protein methyltransferase
Function
Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also mediates monomethylation of 'Lys-56' of histone H3 (H3K56me1) in G1 phase, leading to promote interaction between histone H3 and PCNA and regulating DNA replication. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. May also methylate histone H1. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Also methylates CDYL, WIZ, ACIN1, DNMT1, HDAC1, ERCC6, KLF12 and itself. Recruited to the promoters of target genes through interaction with transcriptional repressor MSX1, leading to the inhibition of myoblast differentiation via transcriptional repression of differentiation factors (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
Q96KQ7

Secondarily ID:
B0UZY2
Q14349
Q5JP83
Q5JQ92
Q5JQA1
Q5JQG3
Q6PK06
Q96MH5
Q96QD0
Q9UQL8
Q9Y331
    Show/Hide
Ensembl ID
ENSG00000204371
HGNC ID
HGNC:14129
Subcellular Location
Nucleus
Chromosome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000237 , 22Rv1
Compound ID Compound Name Compound Formula
CP0042224
N-(1-cyclohexylpiperidin-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)-2-(4-propan-2-yl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C36H59N7O2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0341308
N-[1-(cyclohexylmethyl)piperidin-4-yl]-6-methoxy-7-(3-piperidin-1-ylpropoxy)-2-(4-propan-2-yl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C37H61N7O2
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0046275
2-cyclohexyl-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C30H47N5O2
 1
1
IC50 = 48 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0291908
6-methoxy-2-(4-propan-2-yl-1,4-diazepan-1-yl)-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C32H53N7O2
 1
1 IC50 = 2 nM
CP0046275
2-cyclohexyl-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C30H47N5O2
 11
1 IC50 < 2.5 nM
2 IC50 = 2.5 nM
3 IC50 = 12 nM
4 IC50 < 15 nM
5 IC50 = 15 nM
6 IC50 = 25 nM
7 IC50 = 30 nM
8 IC50 = 55 nM
9 IC50 = 610 nM
10 Ki = 3.7 nM
11 Ki = 18 nM
CP0154811
2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C29H44F2N6O2
 4
1 IC50 < 2.5 nM
2 IC50 = 220 nM
3 Kd = 230 nM
4 Ki = 3.7 nM
CP0158696
2-(azepan-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C30H48N6O2
 2
1 IC50 < 2.5 nM
2 IC50 = 20 nM
CP0203470
6-methoxy-2-piperidin-1-yl-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C29H46N6O2
 2
1 IC50 < 2.5 nM
2 IC50 = 16 nM
CP0338455
6-methoxy-2-morpholin-4-yl-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C28H44N6O3
 1
1 IC50 < 2.5 nM
CP0016974
5'-methoxy-6'-(3-pyrrolidin-1-ylpropoxy)spiro[cyclobutane-1,3'-indole]-2'-amine
   Show/Hide
C19H27N3O2
 3
1 IC50 = 2.8 nM
2 IC50 = 3 nM
3 IC50 = 3.3 nM
CP0209417
N-(1-cyclopropylpiperidin-4-yl)-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C29H42F2N6O2
 1
1 IC50 = 3 nM
CP0341308
N-[1-(cyclohexylmethyl)piperidin-4-yl]-6-methoxy-7-(3-piperidin-1-ylpropoxy)-2-(4-propan-2-yl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C37H61N7O2
 1
1 IC50 = 4 nM
CP0242458
N-(1-cyclopropylpiperidin-4-yl)-2-(1,1-dioxo-1,4-thiazinan-4-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C28H42N6O4S
 1
1 IC50 = 4 nM
CP0281324
2-(4-ethyl-1,4-diazepan-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C31H51N7O2
 1
1 IC50 = 5 nM
CP0042224
N-(1-cyclohexylpiperidin-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)-2-(4-propan-2-yl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C36H59N7O2
 1
1 IC50 = 6 nM
CP0350263
2-[4-(cyclohexylmethyl)-1,4-diazepan-1-yl]-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C36H59N7O2
 1
1 IC50 = 7 nM
CP0222876
6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
   Show/Hide
C28H45N7O2
 2
1 IC50 = 8 nM
2 IC50 = 11000 nM
CP0281327
6-methoxy-7-(3-piperidin-1-ylpropoxy)-2-(4-propan-2-yl-1,4-diazepan-1-yl)-N-(1-propan-2-ylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C33H55N7O2
 1
1 IC50 = 8 nM
CP0231500
7-(2-(2-(Dimethylamino)ethoxy)ethoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C27H45N7O3
 2
1 IC50 = 9 nM
2 IC50 = 6000 nM
CP0350264
2-(4-benzyl-1,4-diazepan-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C36H53N7O2
 1
1 IC50 = 9 nM
CP0224989
6-methoxy-2-(oxan-4-yl)-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C29H45N5O3
 1
1 IC50 = 9 nM
CP0281325
6-methoxy-2-(4-phenyl-1,4-diazepan-1-yl)-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C35H51N7O2
 1
1 IC50 = 10 nM
CP0290010
6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C30H49N7O2
 1
1 IC50 = 10 nM
CP0241960
N-(1-cyclohexylpiperidin-4-yl)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C34H55N7O2
 1
1 IC50 = 11 nM
CP0039320
7-(3-(dimethylamino)propoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C26H43N7O2
 6
1 IC50 = 15 nM
2 IC50 = 43 nM
3 IC50 = 57 nM
4 IC50 = 43000 nM
5 Kd = 23 nM
6 Ki = 2.6 nM
CP0040710
6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine
   Show/Hide
C29H47N7O2
 2
1 IC50 = 20 nM
2 IC50 = 25 nM
CP0345772
2-cyclohexyl-7-[2-[2-(dimethylamino)ethoxy]ethoxy]-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C29H47N5O3
 1
1 IC50 = 21 nM
CP0241952
2-(4-cyclohexyl-1,4-diazepan-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine
   Show/Hide
C35H57N7O2
 1
1 IC50 = 22 nM
CP0344006
2-(azepan-1-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)-N-(1-propan-2-ylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C31H50N6O2
 1
1 IC50 = 31 nM
CP0040703
N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C28H38N6O2
 10
1 IC50 = 67 nM
2 IC50 = 110 nM
3 IC50 = 180 nM
4 IC50 = 290 nM
5 IC50 = 1200 nM
6 IC50 = 1700 nM
7 IC50 = 1900 nM
8 IC50 = 2000 nM
9 IC50 = 2700 nM
10 Kd = 130 nM
CP0043967
2-cyclohexyl-6-methoxy-7-(3-piperidin-1-ylpropoxy)-N-(1-propan-2-ylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C31H49N5O2
 1
1 IC50 = 110 nM
Clinical Information about the Protein
Target 1 ( Histone-lysine N-methyltransferase EHMT2 (EHMT2) )
Target Type Preclinical Target
Disease 3 Target-related Diseases  3
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
2 Breast cancer [ICD-11: 2C60-2C65]
3 Inflammation [ICD-11: 1A00-CA43.1]
Preclinical Drug(s) 3 Preclinical Drugs  3
1 A-366 Preclinical
Solid tumour/cancer
2 BIX-01294 Preclinical
Breast cancer
3 MS012 Preclinical
Inflammation